Cargando…
Lung biopsy in ARDS: is it worth the risk?
Progress in the treatment of acute respiratory distress syndrome (ARDS) has been slow, perhaps in part due to the heterogeneity in the biology underlying this syndrome. Open lung biopsy is a feasible approach to define various subcategories of underlying histology. In experienced hands, with careful...
Autores principales: | Malhotra, Atul, Patel, Sanjay |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750997/ https://www.ncbi.nlm.nih.gov/pubmed/16941755 http://dx.doi.org/10.1186/cc5001 |
Ejemplares similares
-
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
por: Hayes, Daniel F
Publicado: (2013) -
The cost-effectiveness challenge: is it worth it?
por: Knapp, Martin
Publicado: (2015) -
Commentary: Is the juice worth the squeeze?
por: Demmy, Todd L.
Publicado: (2020) -
Commentary: Is the juice worth the squeeze?
por: Lantz, Gurion, et al.
Publicado: (2021) -
Postvaccine Myocarditis: A Risk Worth the Reward?
por: Raman, Betty, et al.
Publicado: (2022)